These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10663638)

  • 1. Effect of P-glycoprotein modulation with cyclosporin A on cerebrospinal fluid penetration of doxorubicin in non-human primates.
    Warren KE; Patel MC; McCully CM; Montuenga LM; Balis FM
    Cancer Chemother Pharmacol; 2000; 45(3):207-12. PubMed ID: 10663638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of doxorubicin concentration by cyclosporin A in brain and testicular barrier tissues expressing P-glycoprotein in rats.
    Hughes CS; Vaden SL; Manaugh CA; Price GS; Hudson LC
    J Neurooncol; 1998 Mar; 37(1):45-54. PubMed ID: 9525837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma and cerebrospinal fluid pharmacokinetics of intravenous oxaliplatin, cisplatin, and carboplatin in nonhuman primates.
    Jacobs SS; Fox E; Dennie C; Morgan LB; McCully CL; Balis FM
    Clin Cancer Res; 2005 Feb; 11(4):1669-74. PubMed ID: 15746072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can celecoxib affect P-glycoprotein-mediated drug efflux? A microPET study.
    de Vries EF; Doorduin J; Vellinga NA; van Waarde A; Dierckx RA; Klein HC
    Nucl Med Biol; 2008 May; 35(4):459-66. PubMed ID: 18482683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of P-glycoprotein-mediated efflux on cerebrospinal fluid concentrations in rhesus monkeys.
    Tang C; Kuo Y; Pudvah NT; Ellis JD; Michener MS; Egbertson M; Graham SL; Cook JJ; Hochman JH; Prueksaritanont T
    Biochem Pharmacol; 2009 Sep; 78(6):642-7. PubMed ID: 19481060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of multidrug resistance reversal agents with P-glycoprotein ATPase activity on blood-brain barrier.
    He L; Liu GQ
    Acta Pharmacol Sin; 2002 May; 23(5):423-9. PubMed ID: 11978192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of high-dose cyclosporine on etoposide pharmacodynamics in a trial to reverse P-glycoprotein (MDR1 gene) mediated drug resistance.
    Lum BL; Kaubisch S; Fisher GA; Brown BW; Sikic BI
    Cancer Chemother Pharmacol; 2000; 45(4):305-11. PubMed ID: 10755319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporin A markedly changes the distribution of doxorubicin in mice and rats.
    Colombo T; Zucchetti M; D'Incalci M
    J Pharmacol Exp Ther; 1994 Apr; 269(1):22-7. PubMed ID: 8169829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I pharmacokinetic study of cyclosporin A combined with doxorubicin.
    Erlichman C; Moore M; Thiessen JJ; Kerr IG; Walker S; Goodman P; Bjarnason G; DeAngelis C; Bunting P
    Cancer Res; 1993 Oct; 53(20):4837-42. PubMed ID: 8402670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I trial of intravenous carboplatin and cyclosporin A in refractory gynecologic cancer patients.
    Chambers SK; Davis CA; Chambers JT; Schwartz PE; Lorber MI; Hschumacher RE
    Clin Cancer Res; 1996 Oct; 2(10):1699-704. PubMed ID: 9816119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma and cerebrospinal fluid pharmacokinetics of valproic acid after oral administration in non-human primates.
    Stapleton SL; Thompson PA; Ou CN; Berg SL; McGuffey L; Gibson B; Blaney SM
    Cancer Chemother Pharmacol; 2008 Apr; 61(4):647-52. PubMed ID: 17541590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma and cerebrospinal fluid pharmacokinetics of the histone deacetylase inhibitor, belinostat (PXD101), in non-human primates.
    Warren KE; McCully C; Dvinge H; Tjørnelund J; Sehested M; Lichenstein HS; Balis FM
    Cancer Chemother Pharmacol; 2008 Aug; 62(3):433-7. PubMed ID: 17960383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and cerebrospinal fluid penetration of daunorubicin, idarubicin, and their metabolites in the nonhuman primate model.
    Berg SL; Reid J; Godwin K; Murry DJ; Poplack DG; Balis FM; Ames MM
    J Pediatr Hematol Oncol; 1999; 21(1):26-30. PubMed ID: 10029808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemosensitization of human hepatocellular carcinoma cells with cyclosporin A in post-liver transplant patient plasma.
    Tong AW; Su D; Mues G; Tillery GW; Goldstein R; Klintmalm G; Stone MJ
    Clin Cancer Res; 1996 Mar; 2(3):531-9. PubMed ID: 9816200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cyclosporin A on the brain regional distribution of doxorubicin in rats.
    Hsieh YJ; Chang CH; Huang SP; Lin CW; Wang MN; Wu YT; Chen YJ; Tsai TH
    Int J Pharm; 2008 Feb; 350(1-2):265-71. PubMed ID: 17935917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma and cerebrospinal fluid pharmacokinetic study of topotecan in nonhuman primates.
    Blaney SM; Cole DE; Balis FM; Godwin K; Poplack DG
    Cancer Res; 1993 Feb; 53(4):725-7. PubMed ID: 8428353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug resistance-reversing agents increase vinblastine distribution in normal tissues expressing the P-glycoprotein but do not enhance drug penetration in brain and testis.
    Arboix M; Paz OG; Colombo T; D'Incalci M
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1226-30. PubMed ID: 9190857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Verapamil P-glycoprotein transport across the rat blood-brain barrier: cyclosporine, a concentration inhibition analysis, and comparison with human data.
    Hsiao P; Sasongko L; Link JM; Mankoff DA; Muzi M; Collier AC; Unadkat JD
    J Pharmacol Exp Ther; 2006 May; 317(2):704-10. PubMed ID: 16415090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The plasma and cerebrospinal fluid pharmacokinetics of sorafenib after intravenous administration in non-human primates.
    Kim A; McCully C; Cruz R; Cole DE; Fox E; Balis FM; Widemann BC
    Invest New Drugs; 2012 Apr; 30(2):524-8. PubMed ID: 21072558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P glycoprotein regulated transport of glutamate at blood brain barrier.
    Liu XD; Liu GQ
    Acta Pharmacol Sin; 2001 Feb; 22(2):111-6. PubMed ID: 11741514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.